The risk of cardiovascular events following treatment for psoriatic arthritis with a biological agent
Rheumatology (Oxford). 2025 Oct 13:keaf487. doi: 10.1093/rheumatology/keaf487. Online ahead of print. ABSTRACT OBJECTIVES: Psoriatic arthritis (PsA) increases cardiovascular disease risk. […]
